Thermo Fisher Scientific Inc (NYSE:TMO)
$ 593.03 15.1 (2.61%) Market Cap: 226.37 Bil Enterprise Value: 248.96 Bil PE Ratio: 38.04 PB Ratio: 4.97 GF Score: 95/100

Thermo Fisher Scientific Inc at Bank of America Merrill Lynch Health Care Conference Transcript

May 14, 2019 / 03:40PM GMT
Release Date Price: $267.39 (+2.42%)
Michael Leonidovich Ryskin
BofA Merrill Lynch, Research Division - Associate

I think we'll get started. Hi, everyone. My name is Mike Ryskin. I'm from the life science tools and diagnostics team here at Bank of America Merrill Lynch. I want to welcome you to our health care conference. I'm here on behalf of Derik De Bruin, the senior analyst on the team. Unfortunately, he couldn't make it today. He's recovering from a recent surgery, but he's in New York and he's following the presentation on webcast. And believe me, he would be here if he could.

So here to start, we have Marc Casper, CEO of Thermo Fisher Scientific. Thank you for joining us, Marc. The format of the session will be a fireside chat, and then towards the end, I'll open it up to Q&A from the audience.

Questions & Answers

Michael Leonidovich Ryskin
BofA Merrill Lynch, Research Division - Associate

So to begin, I thought maybe we could just start with a quick overview of your first quarter results that you announced a few weeks ago. Certainly very robust on the top line,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot